Drug Type Small molecule drug |
Synonyms Aclacinomycin A, Aclarubicin, Aclarubicin Hydrochlorid + [8] |
Target |
Mechanism DNA inhibitors(DNA inhibitors), Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (04 Jun 1981), |
Regulation- |
Molecular FormulaC42H54ClNO15 |
InChIKeyKUSMIBXCRZTVML-PCCPLWKKSA-N |
CAS Registry75443-99-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Aclarubicin Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Breast Cancer | JP | 04 Dec 1981 | |
Leukemia | JP | 04 Jun 1981 | |
Lung Cancer | JP | 04 Jun 1981 | |
Lymphoma | JP | 04 Jun 1981 | |
Ovarian Cancer | JP | 04 Jun 1981 | |
Stomach Cancer | JP | 04 Jun 1981 |
Phase 2 | 67 | xnsfzluxkw(zyucidawgg) = mwulmqmykp kcucotjlfw (ebqougehdr ) View more | Positive | 14 May 2024 | |||
xnsfzluxkw(zyucidawgg) = dcyvwwyfog kcucotjlfw (ebqougehdr ) View more | |||||||
Not Applicable | 43 | IAG group | aufzdgcznv(mwgrruqsfi) = sqjrrekylt jfwaziocxh (erpxlblukm ) View more | - | 21 May 2015 | ||
CAG group | aufzdgcznv(mwgrruqsfi) = ijwmuayvrq jfwaziocxh (erpxlblukm ) View more |